Report Detail

Pharma & Healthcare Global and Japan Nifedipine Market Insights, Forecast to 2026

  • RnM4203169
  • |
  • 14 September, 2020
  • |
  • Global
  • |
  • 132 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Nifedipine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nifedipine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Nifedipine market is segmented into
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets

Segment by Application, the Nifedipine market is segmented into
Primary Pulmonary Hypertension
Heart Failure
Others

Regional and Country-level Analysis
The Nifedipine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nifedipine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Nifedipine Market Share Analysis
Nifedipine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nifedipine business, the date to enter into the Nifedipine market, Nifedipine product introduction, recent developments, etc.
The major vendors covered:
Bayer (Germany)
Actavis (USA)
Teva (Israel)
Pfizer (USA)
Shyndec (China)
Honglin (China)
Huanghai (China)
Yabao (China)


1 Study Coverage

  • 1.1 Nifedipine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Nifedipine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Nifedipine Market Size Growth Rate by Type
    • 1.4.2 Nifedipine Controlled Release Tablets
    • 1.4.3 Nifedipine Extended Action Tablets
  • 1.5 Market by Application
    • 1.5.1 Global Nifedipine Market Size Growth Rate by Application
    • 1.5.2 Primary Pulmonary Hypertension
    • 1.5.3 Heart Failure
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Nifedipine Market Size, Estimates and Forecasts
    • 2.1.1 Global Nifedipine Revenue 2015-2026
    • 2.1.2 Global Nifedipine Sales 2015-2026
  • 2.2 Global Nifedipine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Nifedipine Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Nifedipine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Nifedipine Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Nifedipine Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Nifedipine Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Nifedipine Revenue Forecast by Region (2021-2026)

3 Global Nifedipine Competitor Landscape by Players

  • 3.1 Global Top Nifedipine Sales by Manufacturers
    • 3.1.1 Global Nifedipine Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Nifedipine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Nifedipine Manufacturers by Revenue
    • 3.2.1 Global Nifedipine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Nifedipine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Nifedipine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Nifedipine Revenue in 2019
    • 3.2.5 Global Nifedipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Nifedipine Price by Manufacturers
  • 3.4 Global Nifedipine Manufacturing Base Distribution, Product Types
    • 3.4.1 Nifedipine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Nifedipine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Nifedipine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Nifedipine Market Size by Type (2015-2020)
    • 4.1.1 Global Nifedipine Sales by Type (2015-2020)
    • 4.1.2 Global Nifedipine Revenue by Type (2015-2020)
    • 4.1.3 Nifedipine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Nifedipine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Nifedipine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Nifedipine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Nifedipine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Nifedipine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Nifedipine Market Size by Application (2015-2020)
    • 5.1.1 Global Nifedipine Sales by Application (2015-2020)
    • 5.1.2 Global Nifedipine Revenue by Application (2015-2020)
    • 5.1.3 Nifedipine Price by Application (2015-2020)
  • 5.2 Nifedipine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Nifedipine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Nifedipine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Nifedipine Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Nifedipine Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Nifedipine Sales YoY Growth 2015-2026
    • 6.1.2 Japan Nifedipine Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Nifedipine Market Share in Global Market 2015-2026
  • 6.2 Japan Nifedipine Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Nifedipine Players by Sales (2015-2020)
    • 6.2.2 Japan Top Nifedipine Players by Revenue (2015-2020)
  • 6.3 Japan Nifedipine Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Nifedipine Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Nifedipine Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Nifedipine Price by Type (2015-2020)
  • 6.4 Japan Nifedipine Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Nifedipine Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Nifedipine Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Nifedipine Price Forecast by Type (2021-2026)
  • 6.5 Japan Nifedipine Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Nifedipine Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Nifedipine Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Nifedipine Price by Application (2015-2020)
  • 6.6 Japan Nifedipine Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Nifedipine Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Nifedipine Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Nifedipine Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Nifedipine Market Size YoY Growth 2015-2026
  • 7.2 North America Nifedipine Market Facts & Figures by Country
    • 7.2.1 North America Nifedipine Sales by Country (2015-2020)
    • 7.2.2 North America Nifedipine Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Nifedipine Market Size YoY Growth 2015-2026
  • 8.2 Europe Nifedipine Market Facts & Figures by Country
    • 8.2.1 Europe Nifedipine Sales by Country
    • 8.2.2 Europe Nifedipine Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Nifedipine Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Nifedipine Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Nifedipine Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Nifedipine Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Nifedipine Market Size YoY Growth 2015-2026
  • 10.2 Latin America Nifedipine Market Facts & Figures by Country
    • 10.2.1 Latin America Nifedipine Sales by Country
    • 10.2.2 Latin America Nifedipine Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Nifedipine Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Nifedipine Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Nifedipine Sales by Country
    • 11.2.2 Middle East and Africa Nifedipine Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Bayer (Germany)
    • 12.1.1 Bayer (Germany) Corporation Information
    • 12.1.2 Bayer (Germany) Description and Business Overview
    • 12.1.3 Bayer (Germany) Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Bayer (Germany) Nifedipine Products Offered
    • 12.1.5 Bayer (Germany) Recent Development
  • 12.2 Actavis (USA)
    • 12.2.1 Actavis (USA) Corporation Information
    • 12.2.2 Actavis (USA) Description and Business Overview
    • 12.2.3 Actavis (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Actavis (USA) Nifedipine Products Offered
    • 12.2.5 Actavis (USA) Recent Development
  • 12.3 Teva (Israel)
    • 12.3.1 Teva (Israel) Corporation Information
    • 12.3.2 Teva (Israel) Description and Business Overview
    • 12.3.3 Teva (Israel) Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Teva (Israel) Nifedipine Products Offered
    • 12.3.5 Teva (Israel) Recent Development
  • 12.4 Pfizer (USA)
    • 12.4.1 Pfizer (USA) Corporation Information
    • 12.4.2 Pfizer (USA) Description and Business Overview
    • 12.4.3 Pfizer (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Pfizer (USA) Nifedipine Products Offered
    • 12.4.5 Pfizer (USA) Recent Development
  • 12.5 Shyndec (China)
    • 12.5.1 Shyndec (China) Corporation Information
    • 12.5.2 Shyndec (China) Description and Business Overview
    • 12.5.3 Shyndec (China) Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Shyndec (China) Nifedipine Products Offered
    • 12.5.5 Shyndec (China) Recent Development
  • 12.6 Honglin (China)
    • 12.6.1 Honglin (China) Corporation Information
    • 12.6.2 Honglin (China) Description and Business Overview
    • 12.6.3 Honglin (China) Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Honglin (China) Nifedipine Products Offered
    • 12.6.5 Honglin (China) Recent Development
  • 12.7 Huanghai (China)
    • 12.7.1 Huanghai (China) Corporation Information
    • 12.7.2 Huanghai (China) Description and Business Overview
    • 12.7.3 Huanghai (China) Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Huanghai (China) Nifedipine Products Offered
    • 12.7.5 Huanghai (China) Recent Development
  • 12.8 Yabao (China)
    • 12.8.1 Yabao (China) Corporation Information
    • 12.8.2 Yabao (China) Description and Business Overview
    • 12.8.3 Yabao (China) Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Yabao (China) Nifedipine Products Offered
    • 12.8.5 Yabao (China) Recent Development
  • 12.11 Bayer (Germany)
    • 12.11.1 Bayer (Germany) Corporation Information
    • 12.11.2 Bayer (Germany) Description and Business Overview
    • 12.11.3 Bayer (Germany) Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Bayer (Germany) Nifedipine Products Offered
    • 12.11.5 Bayer (Germany) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Nifedipine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Nifedipine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Nifedipine. Industry analysis & Market Report on Nifedipine is a syndicated market report, published as Global and Japan Nifedipine Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Nifedipine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,108.30
    4,662.45
    6,216.60
    3,623.10
    5,434.65
    7,246.20
    597,597.00
    896,395.50
    1,195,194.00
    325,416.00
    488,124.00
    650,832.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report